Will Apple’s Health Records app change clinical trials?
April 17, 2018
By Neozene

Apple launches Health Records with 39 health systems. How soon will it reach clinical studies? Two months after the beta run, Apple has officially launched its Apple Health Records function, which allows users to access electronic health records from multiple healthcare providers in one place. Now patients of 39 health systems covering hundreds of hospitals and clinics can view their EHR from all participating institutions aggregated together on their iPhone. It means patients and physicians can better view medical information in the healthcare setting, but it could also change the

Read More

FDA chief Gottlieb says ‘holy grail’ flu shot is years off
March 28, 2018
By Neozene

The Centers for Disease Control and Prevention recently reported that flu immunizations have been about 36% effective in the U.S. this year, during a season that’s been particularly severe. No wonder experts are calling for alternatives, but the “holy grail”—a flu shot that fights any strain of virus—is still years away. At a Congressional committee hearing on Thursday, FDA commissioner Scott Gottlieb said “investing in—and working toward—the universal flu vaccine is crucial.” “Unfortunately, given where we are today in the development process, that reality is still many years off,” he

Read More

AAMI Webinar on HFE Reports for Medical Device Manufacturers
March 15, 2018
By Neozene

A new webinar hosted by the Association for the Advancement of Medical Instruments (AAMI) will provide insights into preparing Human Factors Engineering (HFE) test plans and reports that existing regulatory guidance does not fully address. The AAMI webinar, “Writing Human Factors Plans and Reports,” has been developed to cover the lack of sample work products in HFE guidance documents issued by the US Food and Drug Administration and other regulators. The webinar takes place March 15, 2018 at 11am Eastern US time. Topics the webinar will cover include: HFE project plans

Read More